GlassScriptPhysician profile
Ashish Pershad
NPI 1194710657
$112,248.79
in general payments reported to CMS, 2019-2025
34 companies · $6,655 in 2025
The $6,655 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $11K · 2021: $39K · 2022: $11K · 2023: $16K · 2024: $8,484 · 2025: $6,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $7,136 · Consulting Fee: $6,500 · Travel and Lodging: $3,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,900.00 |
| Food and Beverage | $7,135.92 |
| Consulting Fee | $6,500.00 |
| Travel and Lodging | $3,080.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28,371.92 | 2019-2025 | Corevalve Evolut R, Ffrangio, Resolute Onyx |
| Edwards Lifesciences Corporation | $23,544.03 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Pascal |
| Philips North America LLC | $14,103.02 | 2019-2025 | Coronary Other |
| Asahi Intecc USA, INC. | $11,376.18 | 2019-2024 | Peripheral Vascular |
| Medtronic Vascular, INC. | $9,794.81 | 2019-2020 | |
| Abiomed | $4,651.49 | 2019-2025 | |
| Abbott Laboratories | $4,274.04 | 2019-2024 | Mitraclip, Cardiomems |
| Biotronik INC. | $3,916.73 | 2019-2024 | Orsiro Mission, Recross |
| W. L. Gore & Associates, INC. | $3,295.57 | 2019-2020 | |
| Teleflex LLC | $2,447.86 | 2019-2025 | Manta, Guideliner, Supercross |
| Boston Scientific Corporation | $2,275.61 | 2019-2025 | Avvigo Guidance System, General - Vascular Access |
| Livanova USA, INC. | $2,240.12 | 2019-2021 | |
| Terumo Medical Corporation | $318.12 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $249.15 | 2019-2025 | Lifevest |
| Cathworks, INC. | $170.25 | 2024 | Ffrangio |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $169.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $156.93 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $124.54 | 2023 | |
| Cardiac Dimensions, INC. | $96.68 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.93 | 2019-2020 | |
| Amgen INC. | $81.33 | 2019-2022 | |
| Biosense Webster, INC. | $76.51 | 2020 | |
| Ekos Corporation | $64.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $61.52 | 2019-2020 | |
| Atricure, INC. | $59.73 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $56.76 | 2019-2021 | |
| Mimedx Group, INC. | $46.30 | 2025 | |
| Corindus INC. | $38.82 | 2019 | |
| Astellas Pharma US INC | $24.52 | 2019 | |
| Chiesi USA, INC. | $18.34 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.45 | 2023 | Opsumit |
| Heartflow, INC. | $17.38 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $12.66 | 2019 | |
| Cardiovascular Systems INC. | $6.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Pershad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.